Amarillo Biosciences - Home Thu, 15 Nov 2018 21:01:07 -0600 Joomla! - Open Source Content Management en-gb Amarillo Biosciences, Inc. Announces Investor Update


Amarillo, Texas, September 6, 2017 — Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR), has identified certain goals for its future business development, and wishes to share this information with both its shareholders, and the general public.  ABI recognizes that it needs to create new products and get them to market, monetize and commercialize its intellectual property, leverage core technology, and develop research capabilities to become an integrated healthcare enterprise of global distinction.  Additionally, ABI must transform itself from the historically narrow focus in biotechnology to a wide variety of development opportunities in several industry sectors.  By doing so, we can create multiple revenue streams through the implementation of programs (including but not limited to in-licensing) of novel medical, healthcare, and scientific products and processes.  For this strategy to be successful, we have to transform ABI from the traditional single-business unit into three modern, diversified, self-contained business operations: Pharmaceutical, Medical, and Consumer Products.

cshelton [AT] suddenlinkmail [DOT] com (Chrystal Shelton) Featured Latest News Tue, 17 Oct 2017 11:12:19 -0500